ImmuCell Corporation (ICCC) Financials

$5.38

north_east
$0.02 (0.37%)
Day's range
$5.11
Day's range
$5.4
$30M$30M$20M$20M$10M$10M$0$0-$10M-$10MEarning201820182019201920202020202120212022202220232023202420240%0%-10%-10%-20%-20%-30%-30%-40%-40%Profit Margin
Profit Margin
Revenue
Earnings

ICCC Income statement / Annual

Last year (2024), ImmuCell Corporation's total revenue was $26.49 M, an increase of 51.64% from the previous year. In 2024, ImmuCell Corporation's net income was -$2.16 M. See ImmuCell Corporation,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Operating Revenue $26.49 M $17.47 M $18.57 M $19.24 M $15.34 M $13.72 M $10.99 M $10.43 M $9.54 M $10.23 M
Cost of Revenue $18.55 M $13.08 M $10.92 M $10.59 M $8.48 M $6.98 M $5.79 M $5.21 M $4.12 M $3.98 M
Gross Profit $7.94 M $4.40 M $7.65 M $8.66 M $6.86 M $6.74 M $5.19 M $5.22 M $5.42 M $6.25 M
Gross Profit Ratio 0.3 0.25 0.41 0.45 0.45 0.49 0.47 0.5 0.57 0.61
Research and Development Expenses $3.90 M $4.39 M $4.49 M $4.17 M $4.35 M $3.69 M $3.52 M $2.05 M $1.24 M $1.24 M
General & Administrative Expenses $2.22 M $2.13 M $2.26 M $1.73 M $1.72 M $1.69 M $1.74 M $1.52 M $1.45 M $1.29 M
Selling & Marketing Expenses $3.47 M $3.09 M $5.45 M $4.23 M $3.89 M $4.01 M $3.82 M $3.42 M $1.83 M $1.61 M
Selling, General & Administrative Expenses $5.68 M $5.22 M $5.45 M $4.23 M $3.89 M $4.01 M $3.82 M $3.42 M $3.29 M $2.89 M
Other Expenses $0.00 $527,000.00 -$187,000.00 -$326,000.00 $348,000.00 -$314,000.00 -$413,000.00 -$195,000.00 -$24,847.00 $5,635.00
Operating Expenses $9.58 M $10.14 M $9.95 M $8.40 M $8.24 M $7.69 M $7.34 M $5.46 M $4.53 M $4.13 M
Cost And Expenses $28.13 M $23.22 M $20.87 M $18.99 M $16.72 M $14.68 M $13.13 M $10.67 M $8.65 M $8.11 M
Interest Income $0.00 $0.00 $153,100.00 $18,810.00 $27,440.00 $118,283.00 $14,301.00 $16,909.00 $54,662.00 $19,169.00
Interest Expense $0.00 $0.00 $340,878.00 $314,359.00 $412,687.00 $431,788.00 $427,782.00 $218,571.00 $161,697.00 $80,235.00
Depreciation & Amortization $2.69 M $2.72 M $2.49 M $2.47 M $2.36 M $2.27 M $1.52 M $904,435.00 $802,379.00 $529,261.00
EBITDA $1.04 M -$2.50 M $349,990.00 $2.72 M $1.65 M $1.43 M $88,442.00 $684,529.00 $1.72 M $2.65 M
EBITDA Ratio 0.04 -0.14 0.02 0.14 0.11 0.1 0.01 0.07 0.18 0.26
Operating Income Ratio -0.06 -0.33 -0.12 -0.11 -0.09 -0.07 -0.13 -0.02 0.09 0.21
Total Other Income/Expenses Net -$507,000.00 -$21,893.00 -$187,190.00 -$326,512.00 $348,100.00 -$313,505.00 -$413,481.00 -$195,635.00 -$131,882.00 -$58,774.00
Income Before Tax -$2.15 M -$5.77 M -$2.49 M -$69,000.00 -$1.03 M -$1.27 M -$1.86 M -$438,000.00 $758,322.00 $2.06 M
Income Before Tax Ratio -0.08 -0.33 -0.13 -0 -0.07 -0.09 -0.17 -0.04 0.08 0.2
Income Tax Expense $10,000.00 $4,627.00 $8,000.00 $9,000.00 -$10,000.00 $28,000.00 $462,000.00 -$270,000.00 $249,874.00 $850,309.00
Net Income -$2.16 M -$5.77 M -$2.49 M -$78,000.00 -$1.02 M -$1.30 M -$2.32 M -$168,000.00 $508,448.00 $1.21 M
Net Income Ratio -0.08 -0.33 -0.13 -0 -0.07 -0.09 -0.21 -0.02 0.05 0.12
EPS -0.26 -0.75 -0.32 -0.0103 -0.14 -0.19 -0.42 -0.0339 0.12 0.4
EPS Diluted -0.26 -0.75 -0.32 -0.0103 -0.14 -0.19 -0.42 -0.0339 0.12 0.38
Weighted Average Shares Out $8.17 M $7.70 M $7.75 M $7.59 M $7.21 M $6.82 M $5.49 M $4.95 M $4.23 M $3.04 M
Weighted Average Shares Out Diluted $8.17 M $7.75 M $7.75 M $7.59 M $7.21 M $6.82 M $5.49 M $4.95 M $4.34 M $3.17 M
Link